Croda International Plc, a Yorkshire, U.K.-based developer of specialty chemicals, has acquired Enza Biotech AB, a research enterprise established as a spinout company from Lund University in Sweden. Enza Biotech develops next-generation renewable surfactants using carbohydrate-based chemistry. Through the acquisition, Enza Biotech’s patented technology will enhance Croda’s well-established natural and renewable product portfolio, particularly in the personal care, crop care and health care markets, offering the sustainable ingredients customers demand.
Croda acquires Enza Biotech
Company News, Industry News, News | August 24, 2017 | By: ATA
You might also like...
AATCC opens registration for 2027 Proficiency Testing Program
FSA and PAMA accepting independent nominations for board member positions
Morito Scovill Americas promotes Shane McEntyre to CEO
MFA announces advisory board nomination
Registration open for ATA webinar: ETLFs - Elevated Temperature Landfills